Estuardo Aguilar-Cordova
Plus aucun poste en cours
Fortune : 20 M $ au 30/06/2024
Profil
Estuardo Aguilar-Cordova is the founder.
He founded Candel Therapeutics, Inc. in 2002 and held the title of Director from 2022 to 2024.
He also worked as the Deputy Director-Harvard Gene Therapy Initiative at Harvard Medical School and as a Scientific Advisor at Nemucore Medical Innovations, Inc. In terms of education, Dr. Aguilar-Cordova obtained an undergraduate degree from California State University-Bakersfield, a doctorate degree from the University of California, Davis, and another doctorate degree from Universidad Del Valle De Guatemala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CANDEL THERAPEUTICS, INC.
10,60% | 15/05/2024 | 3 153 815 ( 10,60% ) | 20 M $ | 30/06/2024 |
Anciens postes connus de Estuardo Aguilar-Cordova
| Sociétés | Poste | Fin |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Directeur Général | 01/09/2020 |
| Harvard Medical School | Corporate Officer/Principal | - |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Directeur/Membre du Conseil | - |
Formation de Estuardo Aguilar-Cordova
| California State University-Bakersfield | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
| Universidad Del Valle De Guatemala | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
